The new LTS webinar “Oral Thin Films – Tailoring Therapy Need” presented by Dr. Marco Emgenbroich will be held on Nov. 29, 3pm CET/ 9am EST.
This webinar will show the components and science behind OTFs and how they can be used to provide a genuine alternative to current drug delivery systems. You will learn about features, the benefits of using OTFs and much more…
Join our free webinar and register here!
LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (“TTS”) and Oral Thin Films (“OTF”) for the pharmaceutical industry. LTS´ commercial offering encompasses more than 20 marketed products and a diverse pipeline of more than 30 development projects targeting multiple disease indications. LTS’s innovation pipeline contains both partner-funded as well as proprietary, LTS-funded projects. LTS maintains its leading position through the continuous refinement of its core TTS and OTF technologies and by advancing emerging drug delivery technologies, including Micro Array Patches for the transdermal delivery of large molecule, biological actives. Founded in 1984, LTS operates today from two sites in Andernach, Germany and West Caldwell, NJ, USA and a representation in Shanghai, China.